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ABBREVIATIONS
FBS – Fasting Blood Glucose
BMI – Body Mass Index
DM – Diabetes Mellitus
HT –Hypertension
DOS – Duration of stay
RFT – Renal function test
TIA – Transient ischemic attack
CT - Computerised Tomography
MRI – Magnetic Resonance Imaging
SUA – Serum uric acid
ROS – Reactive oxygen species
NOS – Nitric oxide synthase
CAD- Coronary Artery Disease
CVD – Cardiovascular Disease   
CKD - Chronic kidney disease
ABSTRACT
BACKGROUND:
Stroke is socioeconomically a disabling disease with an enormous amount of
loss to family and the country. The incidence and prevalence of stroke is on a rapid
rise with number of risk factors emerging and is in the ascend with the modern
living. Stroke is a disease of the elderly and people with risk factors like
hypertension, diabetes, dyslipidaemia. The increased serum uric acid and
cardiovascular risk factors has been debated for many years and there has been
conflicting results over the study of clinical significance of increased serum uric
acid in cardio and cerebrovascular diseases. Of it studies have concluded that
increased SUA is an important risk factors for the development of CVD with strong
association with diabetes mellitus, hypertension, dyslipidaemia, and BMI. Few
study have shown that increased SUA has good prognosis with outcome of
cerebrovascular disease due to its antioxidant property. Thus this study aims at
study the levels of serum uric acid with other risk factors and its role in influencing
the risk of incidence of acute ischemic stroke.
AIMS AND OBJECTIVES :
1. To identify the role of serum uric acid in influencing the risk of acute  ischaemic
stroke.
2. To identify whether any association exists between age, sex, hypertension,
diabetes, dyslipidaemia, renal parameters and BMI and serum uric acid level.
METHODOLOGY:
The study was carried out in acute ischemic stroke patients admitted in medical
wards under the department of general medicine in Government Vellore medical college
and hospital (GVMCH), Vellore. A sample of 100 patients were include in the study after
meticulously scrutinising the patients through a well prepared proforma over a period of
one year starting from 01 September 2016 to 31 August 2017. After prior Institutional
Ethical clearance and obtaining informed consent, the participants satisfying the inclusion
criteria were asked detailed history and clinical examination was performed according to
the well-designed proforma cited below.
RESULTS:
The mean age of the study subjects was 61.14 years. Most of the patients belonged
to the age group 50 -70years. Out of 100 cases, there were 65 (65.0%) males and
35(35.0%) females. The Male to Female sex ratio was 1.85:1. Of the 100 patients 66 had
normal BMI and 34 patients had abnormal BMI. Fasting blood sugar was elevated in 50
patients and 50 patients had normal fasting blood sugar. Of the 100 patients 68 patients
had history of hypertension, 26 people were smokers.
Overall 69 patients had abnormal lipid profile of which 54 patients had elevated total
cholesterol,60 patients had elevated LDL cholesterol,69 had hypertriglyceridemia and 30
had low HDL cholesterol. Clinically 81 patients had elevated systolic bp and 57 patients
had elevated diastolic bp. Serum uric acid was elevated in 46 patients in our study with
acute ischemic stroke.
CONCLUSION :
Serum Uric acid is an important risk factor for the onset of acute ischemic stroke
independent of age, BMI, hypertension, diabetes, dyslipidemia. Of which most significant
association was found with BMI, Total cholesterol, Serum triglycerides, LDL Cholesterol,
Systolic and Diastolic Blood Pressure.
KEYWORDS:
Acute ischemic stroke, Serum uric acid, Diabetes mellitus, Hypertension,
Dyslipidaemia, Antioxidants, Systolic and Diastolic Blood Pressure, BMI.
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1INTRODUCTION
STROKE (cerebrovascular disease) is ranked the most common cause of death
after ischemic heart disease and cancer consecutively. It is the most common cause of
social and economic burden due to increased morbidity and mortality in middle aged and
elderly. Stroke is the major cause of disability in India with more than million adults
affecting yearly and has to adapt a life with disability and needing other people to assist
their day to day activity .(1)
India has become a country with stroke epidemic like other developing countries in
the recent years. The estimated adjusted prevalence rate of stroke range, 84-262/100,000
in rural and 334-424/100,000 in urban areas. The incidence rate is 119-145/100,000 based
on the recent population based studies. There is a huge variation in the burden of stroke
regionally .Stroke units, Thrombolysis, and Rehabilitation are predominantly available in
urban areas, particularly in private sector hospitals. (2)
As a first step, the Government of India has started the National Programme for
Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases & Stroke
(NPCDCS). The government is focusing on early diagnosis, management, infrastructure,
public awareness, and capacity building at different levels of health care for all the non-
communicable diseases including stroke. An organised effort from both the government
and the private sector is needed to tackle the rising stroke burden in India.(2)
In acute phase of stroke the mortality rate is as high as 20%, Thus it is vital on our
part to establish the risk factors as early as possible to prevent the catastrophe.
Stroke due to cerebral ischemia initiates a complex cascade of metabolic events
that leads to generating nitric oxide and free oxygen radicals. During ischemia, the activity
2of NOS plays a vital role of which NOS1, NOS2 are harmful but NOS3 is helpful in
vasodilatation of the cerebral vessels in the ischemic penumbra. These free radicals and
reactive oxygen species (ROS) mediate a great part of injuries appearing after a transitory
ischemic attack or during permanent ischemia, modifying macromolecules especially
DNA, initiating apoptosis and necrosis. Free radicals are liberated from a variety of
sources, including inflammatory cells, dysfunctional mitochondria and excitotoxic
mechanisms stimulated by increased glutamate and aspartate concentrations.(3)
Hydroxyl radicals (formed from hydrogen peroxide) peroxynitrite and superoxide
are powerful radicals that can cause lipid peroxidation, a self-propagating chain reaction,
that irreversibly damages plasma and mitochondrial membranes. Oxyradical production
and cellular calcium overload are believed to contribute to the damage and death of
neurons that occurs following cerebral ischemia in victims of stroke. (3)
Thus, in acute ischemic stroke due to reduced or complete cut off of the blood
supply to the brain cause the accumulation of reactive oxygen species (hydrogen peroxide
and peroxynitrite), and lipid peroxidation associated with each insult. Mitochondrial
function is also compromised by the excitotoxic and metabolic insults.  This metabolic
insult causes delayed elevations of intracellular free calcium levels induced by glutamate
and cyanide is significantly essential for the cellular necrosis and damage in neurons.
Some study data demonstrate a neuroprotective action of uric acid that involves
suppression of oxyradical accumulation, stabilization of calcium homeostasis, and
preservation of mitochondrial function, and was preserved in neurons treated with uric
acid(4).Thus showing that a balance between oxidative free radicals and antioxidants play
a vital role in the pathophysiology of stroke.
3Uric acid is the end product of purine degradation. It is catalysed by the enzyme
xanthine oxidase, which is responsible for the production of uric acid and damaging free
radicals. In human beings serum uric acid is the most important aqueous antioxidant
occupying more than two third of the free radical scavenging activity of the plasma.This is
a central link in the association between serum uric acid and myocardial ischemia,
myocardial dysfunction and non-cardiac function, which is determined primarily by
impaired peripheral blood flow. Uric acid can serve as a marker of pathophysiological
mechanisms in patients with cardiovascular disease, which may explain why serum uric
acid contains prognostic information.
It was  therefore considered than SUA to be neuroprotective(5) but a number of
epidemiological studies has shown SUA as an risk factor for the occurrence of stroke.
Framingham study was the first epidemiological study to suggest that uric acid levels as
a link between cardiovascular disease and other risk factors like hypertension ,CKD,
dyslipidaemia ,and use of diuretics (6).There are  a number of epidemiological studies
have supporting evidence that serum uric acid is helpful in assessing the risk  of
cardiovascular events, hypertension, congestive heart failure and Type II diabetes mellitus
and acute ischemic stroke and MI(7).
The Rotterdam study by Bos et al. did a study on 4385 participants to study  the
risk of stroke and MI even  after adjusting with relevant confounders  the study concluded
that uric acid is a strong risk factor  for the development of stroke (8).
Chen et al. conducted a  large Chinese prospective cohort study with 41879 men
and 48514 women participants aged equal or more than thirty five years of age  to
4compare the  all-cause mortality and mortality  from  that of total CVD,ischemic stroke
,hypertension and CAD with uric acid and concluded that hyperuricemia was an
independent risk factor of mortality from all causes, total cvd ,ischemic stroke ,and
CAD(9) .Inhibition of xanthine oxidase with allopurinol may be used in future treatment
of  stroke and heart patients.(10)Thus our study aims at determining the role of serum uric
acid in a setting of  acute ischemic stroke.
5AIMS AND OBJECTIVES
1. To identify the role of serum uric acid in influencing the risk of  acute ischaemic
stroke.  
2. To identify whether any association exists between age, sex, hypertension, diabetes,
dyslipidemia, renal parameters and BMI and serum uric acid level in patients with
acute ischemic stroke.  
6REVIEW OF LITERATURE
DEFINITIONS
STROKE:
A stroke or cerebrovascular accident is a rapidly developing clinical symptoms and
or signs of focal and at times global (applied to patients in deep coma and to those with
subarachnoid haemorrhage) loss of cerebral function, with symptoms lasting for more than
24 hours or leading to death, with no apparent vascular cause (11)
TIA: (TRANSIENT ISCHEMIC ATTACK)
By applying this definition transient ischemic attack (TIA), which is defined to last
less than 24 hours, and patients with stroke symptoms caused by subdural haemorrhage,
tumours, poisoning, or trauma are excluded. (11)
ANATOMY OF CEREBRAL CIRCULATION ARTERIES OF THE BRAIN
Two internal carotid arteries and 2 vertebral arteries supply the brain. The 4 arteries
lie within the substance of subarachnoid space and their branches anastamose on the
inferior surface of the brain to form the circle of Willis.
INTERNAL CAROTID ARTERY:
The left common carotid artery arises directly from the aorta and the right common
carotid from the innominate artery. The internal carotid artery begins at the bifurcation of
the common carotid artery. This ascends the neck and perforates the base of the skull by
passing through the carotid canal of the temporal bone. The artery then runs horizontally
forward through the cavernous sinus and emerges on the medial side of the anterior clinoid
process by perforating the duramater. It now enters the subarachnoid space by piercing the
7arachnoid matter and turns posteriorly to the region of the medial end of the lateral
cerebral sulcus. Here it divides into the anterior and middle cerebral arteries.
VERTEBRAL ARTERY
The vertebral artery is a branch of the first part of the subclavian artery, climbing
up the neck passing through the foramina in the transverse process of the upper six
cervical vertebrae entering the skull through the foramen magnum and piercing the  both
the dura and arachnoidmater to enter the subarachnoid space. It then passes upward,
forward and medially on the medulla oblongata. At the lower border of the pons, it joins
vessel of the opposite side to form the basilar artery.
BRANCHES OF THE CEREBRAL PORTION
OPHTHALMIC ARTERY:
The ophthalmic artery which is a branch of the internal carotid artery enters the orbit
through the optic canal below and lateral to the optic nerve. It supplies the eye and other
orbital structures and its terminal branches supply the frontal area of the scalp, the ethmoid
and frontal sinuses and the dorsum of the nose.
POSTERIOR COMMUNICATING ARTERY:
This a small vessel originating near the terminal bifurcation of the internal carotid
artery .The posterior communicating artery runs posteriorly above the oculomotor nerve to
join the posterior cerebral artery to form part of the circle of Willis.
8CHOROIDAL ARTERY:
The choroidal artery is a small branch that passes posteriorly, close to the optic
tract, enters the inferior horn of lateral ventricle and ends in the choroids plexus. It gives
off small branches to the crus cerebri, lateral geniculate body, optic tract and the internal
capsule.
FIGURE 1: MAJOR ARTERIAL BLOOD  SUPPLY TO THE BRAIN
(source of image:(12) http://www.strokecenter.org/professionals/brain-
anatomy/blood-vessels-of-the-brain/)
ANTERIOR CEREBRAL ARTERY:
It runs forward and medially superior to the optic nerve and enters the longitudinal
fissure of cerebrum. Here it joins with its fellow on the opposite side by means of the
anterior communicating artery. It curves backward over the corpus callosum. The cortical
9branches supply the whole of the surface of the cerebral cortex as far back as the parieto-
occipital sulcus. They also supply a strip of cortex about 1 inch wide on the adjoining
lateral side. The anterior cerebral artery thus supplies the leg area of the precentral gyrus.
A group of central branches pierces the anterior perforated substance and helps to supply
the parts of the lentiform and caudate nuclei and the internal capsule.
Figure 2: Anterior Cerebral Artery Blood Supply to the Brain.
(source of image:(12) http://www.strokecenter.org/professionals/brain-
anatomy/blood-vessels-of-the-brain/)
MIDDLE CEREBRAL ARTERY:
It is the largest branch of the internal carotid artery, runs laterally in the lateral
cerebral sulcus. Cortical branches supply the entire lateral surface of the
hemisphere, except for the narrow strip supplied by the hemisphere, which are
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supplied by the anterior cerebral artery, the occipital pole and the inferolateral
surface of the posterior cerebral artery.
This artery thus supplies the whole motor cortex except the leg area. Central
branches enter the anterior perforated substance and supply the lentiform and
caudate nuclei and the internal capsule.
Figure 3: Middle Cerebral Artery Blood Supply to the Brain.
(source of image:(12) http://www.strokecenter.org/professionals/brain-
anatomy/blood-vessels-of-the-brain/)
BRANCHES OF THE CRANIAL PORTION MENINGIAL BRANCHES.
These are small branches and they supply the bone and dura and the posterior
cranial fossa.
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POSTERIOR SPINAL ARTERY
The posterior spinal artery may arise from the vertebral artery or the Posterior
inferior cerebellar artery. It descends on the posterior surface of the spinal cord close to
the posterior roots of the spinal nerves. Radicular arteries that enter the vertebral canal
through the intervertebral foramina reinforce the branches.
ANTERIOR SPINAL ARTERY
It is formed from a contributory branch from each vertebral artery near its
termination. The single artery descends on the anterior surface of the medulla oblongata
and the spinal cord and is embedded in the piamater along the anterior median fissure. The
radicular arteries that enter the vertebral canal through the vertebral foramen reinforce the
artery.
POSTERIOR INFERIOR CEREBELLAR ARTERY
This largest branch of the vertebral artery passes on an irregular course between
the medulla and cerebellum. It supplies the inferior surface of the vermis, central nuclei of
cerebellum and the under surface of the cerebral hemisphere. It also supplies the medulla
oblongata and the choroidal plexus of the fourth ventricle.
MEDULLARY ARTERIES
These are very small branches that are distributed to the medulla oblongata.
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BASILAR ARTERY
The basilar artery, formed by the union of the 2 vertebral arteries, ascends in the
groove on the anterior surface of the pons. At the upper border of the pons, it divides into
2 posterior cerebral arteries.
BRANCHES OF THE BASILAR ARTERY AND PONTINE
ARTERIES.
These are numerous small arteries that enter the substance of the pons.
LABRINTHINE ARTERY
This is a long narrow artery that accompanies the facial and the Vestibulocochlear
nerves into the internal acoustic meatus and supplies the internal ear. It often arises as a
branch of the anterior inferior cerebellar artery.
ANTERIOR INFERIOR CEREBELLAR ARTERY
This artery passes posteriorly and laterally and supplies the anterior and inferior part
of the cerebellum, a few branches pass to pons and upper part of the medulla.
SUPERIOR CEREBELLAR ARTERY
This arises close to the termination of the basilar artery. It winds around the cerebral
peduncle and supplies the superior surface of the cerebellum. It also supplies the pons, the
pineal gland and the superior medullary velum.
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POSTERIOR CEREBRAL ARTERY
This curves laterally and backwards around the mid brain and is joined by the
posterior communicating branch of the internal carotid artery. Cortical branches supply the
inferolateral and medial surfaces of the temporal lobe and lateral and medial surfaces of
the occipital lobe. Thus it supplies the occipital lobe.
Central branches pierce the brain substance and supply palis of the thalamus, the
lentiform nucleus, the midbrain, the pineal gland and the medial geniculate body. A
choroidal branch enters the inferior horn of the lateral ventricle and supplies the choroid
plexus.
Figure 4: Posterior Cerebral Artery Blood Supply to the Brain
(source of image:(12) http://www.strokecenter.org/professionals/brain-
anatomy/blood-vessels-of-the-brain/)
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CIRCLE OF WILLIS :
Figure 5: Circle of Willis
(source of image:(12) http://www.strokecenter.org/professionals/brain-
anatomy/blood-vessels-of-the-brain/)
CIRCLE OF WILLIS:
The circle of Willis lies in the interpeduncular fossa at the base of the brain. It is
formed by anastomosis between the two internal carotid arteries and the two vertebral
arteries. The anterior communicating, the anterior cerebral, internal carotid, posterior
communicating, posterior cerebral, and the basilar arteries all contribute to the circle. The
circle of Willis allows blood that enters either by the internal carotid or the vertebral
arteries to be distributed to any part of either cerebral hemisphere. The cortical and central
branches arise from the circle and supply the brain substance.
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ARTERIES TO SPECIFIC BRAIN AREAS
Mainly the medial and lateral striate central branches of the middle cerebral artery
supply the corpus striatum and the internal capsule; the central branches of the anterior
cerebral artery supply the remainder of the structures.
The posterior cerebral, posterior communicating and basilar arteries supply the
thalamus.
The posterior cerebral, superior cerebellar, and basilar arteries supply the mid
brain.
The basilar and anterior, inferior and superior cerebellar arteries supply the pons.
The vertebral, anterior and posterior spinal, posterior inferior cerebellar and basilar
arteries supply the medulla oblongata.
VEINS OF THE BRAIN EXTERNAL CEREBRAL VEINS
The superior cerebral veins pass upward over the lateral surface of the cerebral
hemisphere and empty into the superior sagittal sinus. The superficial middle cerebral
veins drain the lateral surface of the cerebral hemisphere; it runs inferiorly in the lateral
sulcus and empties into the cavernous sinus. The deep middle cerebral vein drains the
insula and is joined by the anterior cerebral vein and striate veins to form the basilar vein.
The basilar vein ultimately joins the great cerebral vein, which in turn drains into the
straight sinus.
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INTERNAL CEREBRAL VEINS
There are two internal veins, and the union of the thalamo-striate vein and the
choroidal vein at the interventricular foramen forms them. These two veins form the great
cerebral vein that drains into the straight sinus.
EPIDEMIOLOGY OF CEREBROVASCULAR DISEASES IN INDIA
Stroke is becoming an important cause of mortality and disability in India driven
by various factors and demography. According to the India stroke factsheet updated in
2012, the estimated age-adjusted prevalence rate for stroke ranges between 84/100,000
and 262/100,000 in rural and between 334/100,000 and 424/100,000 in urban areas.(2)
stroke fact sheet India. [Accessed 21 July 2013].
http://www.sancd.org/Updated%20Stroke%20Fact%20sheet%202012.pdf.
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TYPES OF STROKE :
The pathological classification of stroke is based on the types of disturbance in the
blood circulation of the brain.
ISCHEMIC STROKE (INFARCTION) :
Ischemic stroke occurs due to ischemia of the partial or all the territory of the
occluded artery due to one of the several reasons, The major one being thrombotic cerebral
infarct due atherosclerotic occlusion of the carotid and cerebral arteries. Secondly, embolic
ischemic infarction from a clot in the cerebral arteries from other parts of the arterial
system. Lacunar cerebral infarcts are minute infarcts due to chronic hypertension due to
local pathology in the territory of small penetrating arteries.
HEMORRHAGIC STROKE
Intracerebral bleeding is other important cause of stroke which can be spontaneous
or traumatic, There are a number of causes for spontaneous hemorrhage now the most
important cause being hypertension, and in the older age the cause of hemmorrhage due to
hypertension is cortical amyloid angiopathy. Other rare causes are Vascular malformations
, Bleeding disorders, Rupture of aneurysms (13)
PATHOPHYSIOLOGY OF ISCHEMIC STROKE:
A Ischemic stroke happens when the blood flow to the brain is hindered, resulting
in variable degree of neurological deficit depending on degree of occlusionof the involved
blood vessel and area of involvement.
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PATHOPHYSIOLOGY OF ISCHAEMIC STROKE:
Ischaemic strokes can be broadly subdivided into thrombotic and embolic strokes.
The most common cause of narrowing of the blood vessel is atherosclerosis, as the
size of the fatty atherosclerotic plaque grows in size the luminal size reduces eventually
leading to reduced blood supply to the brain.
THROMBOTIC STROKE
Occlusion of the blood vessel occurs due to blood clot formation of the damaged
atherosclerotic plaque.
EMBOLIC STROKE
Occlusion of the blood vessels occur due to blood clot and debris from elsewhere
in the body travelling the vessels and occluding narrower blood vessels.
Based on the aetiology of ischaemic stroke, a more accurate sub-
classification is generally used:(14)
 Large Artery Disease – atherosclerosis of large vessels, including the internal
carotid artery, vertebral artery, basilar artery, and other major branches of the Circle
of Willis.
 Small Vessel Disease – changes due to chronic disease, such as diabetes,
hypertension, hyperlipidaemia, and smoking, that lead decreased compliance of the
arterial walls and/or narrowing and occlusion of the lumen of smaller vessels.
 Embolic Stroke – the most common cause of an embolic stroke is atrial fibrillation.
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 Stroke Of Determined Aetiology – such as inherited diseases, metabolic disorders,
and coagulopathies.
 Stroke of Undetermined Aetiology – after exclusion of all of the above.
ISCHAEMIC BRAIN OEDEMA:
Ischaemic brain oedema appears to involve two distinct processes, The first
process occurs during the initial phase of infarction and before structural damage
has occurred. Involves an increase in tissue Na+ and water content accompanying
increased pinocytosis and Na+, K+ ATPase activity across the endothelium. This
phenomenon is augmented by reperfusion. A second process results after infarction
of both the parenchyma and the vasculature after disruption of blood brain barrier
with extravasation of serum proteases additionally apart from the major osmotic
action of sodium. This results in cellular softening and swelling.
Figure 6: Ischemic Penumbra
SOURCE: (Source: http://neuro4students.wordpress.com/pathophysiology)
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ISCHEMIC PENUMBRA:
The ischemic penumbra is defined as area surrounding the ischemic zone which is
functionally silent due to reduced blood flow but metabolically active and hence they are
salvageable if blood flow to the penumbra region is restored.
THE ISCHAEMIC CASCADE:
After seconds to minutes of cerebral ischaemia, the ischaemic cascade is initiated.
This is a series of biochemical reactions in the brain and other aerobic tissues, which
usually goes on for two to three hours, but can last for days, even after normal blood flow
returns.
FLOW CHART OF ISCHEMIC CASCADE:
Figure 7: The ischaemic cascade
(Source: http://neuro4students.wordpress.com/pathophysiology)
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IMPORTANT STEPS OF THE ISCHAEMIC CASCADE
1. Without adequate blood supply and thus lack of oxygen, brain cells lose their ability
to produce energy - particularly adenosine triphosphate (ATP).
2. Cells in the affected area switch to anaerobic metabolism, which leads to a lesser
production of ATP but releases a by-product called lactic acid.
3. Lactic acid is an irritant, which has the potential to destroy cells by disruption of the
normal acid-base balance in the brain.
4. ATP-reliant ion transport pumps fail, causing the cell membrane to become
depolarized; leading to a large influx of ions, including calcium (Ca++), and an efflux
of potassium.
5. Intracellular calcium levels become too high and trigger the release of the excitatory
amino acid neurotransmitter glutamate.
6. Glutamate stimulates AMPA receptors and Ca++-permeable NMDA receptors, which
leads to even more calcium influx into cells.
7. Excess calcium entry overexcites cells and activates proteases (enzymes which
digest cell proteins), lipases (enzymes which digest cell membranes) and free
radicals formed as a result of the ischaemic cascade in a process called
excitotoxicity.
8. As the cell's membrane is broken down by phospholipases, it becomes more
permeable, and more ions and harmful chemicals enter the cell.
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9. Mitochondria break down, releasing toxins and apoptotic factors into the cell.
10. Cells experience apoptosis.
11. If the cell dies through necrosis, it releases glutamate and toxic chemicals into the
environment around it. Toxins poison nearby neurons, and glutamate can overexcite
them.
12. The loss of vascular structural integrity results in a breakdown of the protective
blood brain barrier and contributes to cerebral oedema, which can cause secondary
progression of the brain injury.(15)(16)
RISK FACTORS OF STROKE:
AGE
Age is a non-modifiable risk factor. A large number of epidemiological studies
have shown that the increase in age is associated with increased incidence of
atherosclerosis and cardiovascular disease like myocardialinfarction, stroke.
Although Age is not related to the severity and type of stroke, Age independently
influences stroke outcome selectively in aspect of activity of daily living but not in terms
of neurological aspect suggesting a poorer compensatory ability in elderly stroke patients.
Therefore, rehabilitation of elderly stroke patients should be focused more on ADL and
compensation rather than on the recovery of neurological status.(17)
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SEX
Male are associated with increased risk of stroke(18) The association of
hyperuricemia with hypertension was stronger in males than in females, and middle-aged
men with hyperuricemia had greater association with hypertension.
RACE
Black race is associated with increased risk of stroke than the whites as the
prevalence of hypertension and diabetes mellitus was more than whites.
HYPERTENSION:
Hypertension is one of the most important causative factor for stroke (ischemic and
haemorrhagic). In India, ICMR multicentric study on risk factors for stroke found
Hypertension, Smoking, Diabetes and Low haemoglobin as risk factors. According to
them 40% of stroke can be attributed to systolic blood pressure more than 140 mm of
mercury. A large Chinese study consisting of 2253 patients suggested that over 49.5
percent of patient with stroke had hypertension. Studies from this also shows the benefit of
stroke in hypertensive patients treated with anti-hypertensive drugs.(19).
DIABETES MELLITUS:
Diabetes is a strong risk factor for stroke. Diabetes influences stroke in several
aspects: in age, in subtype, in speed of recovery, and in mortality. Increased glucose levels
on admission independently increase mortality from stroke(20). Insulin resistance plays a
vital key role in the causal relationship between metabolic syndrome, Type 2 diabetes and
hyperuricemia. Hyperuricemia and insulin resistance share a bidirectional causal effect
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that should be evaluated further more. Diabetic patients with retinopathy and autonomic
neuropathy are particularly at high risk for atherosclerosis.(21)
SMOKING:
The risk of stroke increased as the number of cigarettes smoked increased. The
relative risk of stroke in heavy smokers (>40 cigarettes per day) was twice that of light
smokers (fewer than ten cigarettes per day).
Lapsed smokers developed stroke at the same level as non-smokers soon after
stopping. Stroke risk decreased significantly by two years and was at the level of non-
smokers by five years after cessation of cigarette smoking. Cigarette Smoking is a Risk
Factor for Stroke(22).
CLAUDICATION:
Claudication is a symptomatic clue for the increased risk of cardiovascular disease
probably suggestive of atherosclerosis of the vessels. ARIC study suggest that uric acid
well correlates with the accelerated atherosclerosis and hence increased risk of stroke.(23)
ATRIAL FIBRILLATION:
Framingham study examined the incidence of stroke in nonrheumatic atrial
fibrillation, hypertension, coronary heart disease, and cardiac failure patients the Age-
adjusted incidence of stroke was more than twice in the presence of coronary heart disease
and thrice in the presence of hypertension. The risk quadrupled in subjects with cardiac
failure and a near fivefold excess when atrial fibrillation was present. In persons with
coronary heart disease or cardiac failure, atrial fibrillation doubled the stroke risk in men
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and trebled the risk in women. Data also suggest that the elderly are more prone to stroke
in the presence of atrial fibrillation .(24)
CAROTID ARTERY DISEASE:
Ischemic stroke is often a sequel of atherosclerotic risk factors(25). Carotid intima-
media thickness (CIMT) is a surrogate marker of early atherosclerotic changes. Age-
specific value of CIMT was significantly higher in stroke cases than in age-matched
controls across all age groups. Right CIMT, along with the history of hypertension are
important risk factors for ischemic stroke in the younger age group (20-40 years). With
increasing age, along with the history of HTN and right CIMT, presence of plaque and
daily smoking are also significant risk factors. CIMT is significantly related to the daily
alcohol and smoking intake and the presence of plaques. Right CIMT is positively related
to increasing age in normal population. Right CIMT and comorbid HTN are significant
risk factors associated with the development of ischemic stroke across all
adult age groups. Studies suggest that intima–media thickness of the common carotid
artery and the internal carotid artery is strongly associated with the risk of myocardial
infarction and stroke in asymptomatic older adults.(26)
TIA (TRANSIENT ISCHEMIC ATTACK)
Transient ischemic attacks (TIAs) have been found to be a strong predictor of
subsequent stroke and death. Coull et al. found in their study the estimated stroke risks
after a TIA were 8.0%  at seven days, 11.5%  at one month, and 17.3% at three
months.(27).
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OTHER RISK FACTORS :
Abdominal obesity, plasmafibrinogen, homocysteine, dietary measures, snoring,
corneal arcus, psychological factors, diagonal ear lobe crease, physical inactivity,
maternal history of stroke, left ventricular hypertrophy, peripheral vascular disease,
alcohol consumption,  oral contraceptives, plasma factor seven factor coagulant activity.
DIAGNOSIS OF STROKE SUBTYPE USING IMAGING (28)(29) 
The basic aims of imaging, in patients who have symptoms of stroke are 
 To document the presence or absence of haemorrhage. This  information is
critical as the treatment of the two vary.
 To determine the location and extend of brain damage.  
 To assess the current and impending herniation.  
 To exclude other entities, which may mimic stroke syndrome.  
 To find out the cause of stroke.  
Acute infarcts are more frequently visible on MRl than on CT scans. On
admission, approximately 90% of the MRI are positive compared to 60% in CT scans in
acute infarcts.  
COMPUTERISED TOMOGRAPHY OF ISCHAEMIC STROKE  
The CT appearance of cerebral infarction is time dependent. Although the
findings may be detected within 6 -8 hours of onset, CT may be normal up to 24
hours.
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 HYPER ACUTE INFARCT (LESS THAN 12 HOURS)
Normal 50 -60%  
Hyper dense artery 25 -50%  
Obscuration of lentiform nuclei. 
 ACUTE (12 - 24 HOURS)  
Loss of grey white interfaces (insular ribbon sign, obscuration of cortex medullary
white matter border)  
Low density basal ganglia.  
Sulcal effacement  1 – 3 days  
Increasing mass effect.  
Wedge shaped low-density area that involves both grey and white matter.  
Haemorrhagic transformation may occur.  
 4-7 DAYS 
Gyral enhancement  
Mass effect, edema persist.  
 1-8 WEEKS 
Contrast enhancement persists.  
Mass effect resolves  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 MONTHS TO YEARS 
Encephalomalacic change  
Volume loss and  
Rarely calcification.
MULTIMODAL MAGNETIC RESONANCE IMAGING OF
ISCHEMIC STROKE :
The multimodal MRI approach for acute stroke evaluation includes
A. Diffusion-weighted imaging (DWI)
B. Perfusion weightedimaging (PWI)
C. MR angiography
D. Gradient echo
E. Fluid-attenuated inversion recovery
F. T2-weighted sequences.
Standard MRI sequences (T1 weighted, T2 weighted, and proton density) are
relatively insensitive to the changes of acute ischemia.
DWI SEQUENCE (diffusion-weighted imaging)
DWI allows visualization of ischemic regions within minutes of symptom onset
and early identification of the lesion size, site, and age.DWI also provides information
about the involved vascular territory and has a high sensitivity (88% to 100%) and
specificity (95% to 100%) for detecting ischemic lesions, even at very early time points.
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PWI (PERFUSION WEIGHTED IMAGING)
PWI analytical method focus on identifying the highest correlation of ischemic
volume with acute clinical deficits (symptomatic hypoperfusion) or with volume of
chronic infarct (tissue at risk).
GRADIENT ECHO SEQUENCE:
Gradient echo sequences also have the ability to detect clinically silent prior micro
bleeds not visualized on CT scan
MR ANGIOGRAPHY:
MR angiography is increasingly used for non-invasive screening of the extracranial
and intracranial circulation
TREATMENT OF ACUTE ISCHEMIC STROKE(28)(30)
 Early evaluation of diagnosis and supportive treatment
 Reperfusionstrategies
 Neuroprotective agents
 Supportive care
Emergency care for acute complications is of utmost importance as if unattended
can be fatal in most cases of stroke. It includes protection of airway to avoid obstruction,
hypoventilation and aspiration pneumonitis. Care should be taken to prevent cerebral
edema and the factors that exacerbate cerebral edema like Hypoxia, hyperthermia,
hyperventilation, hypovolemia, arterial hypertension, cardiac arrhythmias.
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If the patient develops Acute cerebral oedema it should be treated with mannitol
(20%) solution 1g/kg over 30 min. bolus, followed by 0.25 - 0.5 gm/kg over 30 - 60 min
every 4 - 6 hours. The usual maximal dose is 2 g/kg.
Holter monitoring is recommended atleast for 24 hours to screen for atrial
fibrillation and other potentially serious cardiac arrhythmias that would necessitate
emergency cardiac interventions.
Patients in whom are eligible to be treated with intravenous rtPA and has elevated
blood pressure should their blood pressure carefully lowered so that their systolic blood
pressure is <185 mmHg and their diastolic blood pressure is <110 mmHg before
fibrinolytic therapy is initiated. If medications are given to lower blood pressure the blood
pressure should be stabilized at the lower level before beginning treatment with
intravenous rtPA and maintained below 180/105 mmHg for at least the first 24 hours after
intravenous rtPA treatment. No definitive guidelines are there for definitive treatment of
hypertension but consensus to reduce the blood pressure if systolic pressure >200 to 220
mmHg,diastolic pressure >110 to 120 mmHg with caution that precipitous decrease in
blood pressure decreases local perfusion.
Airway support and ventilator assistance are rec- commended for the treatment of
patients with acute stroke who have decreased consciousness or who have bulbar
dysfunction that causes compromise of the airway Supplemental oxygen should be
provided to maintain oxygen saturation >94%
As hyperthermia (temperature >38°C) has poor outcome source of hyperthermia
should be diagnosed and treatment should be and treated promptly.
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Hypovolemia should be corrected with intravenous normal saline, and cardiac
arrhythmias that might be reducing cardiac output should be corrected
Strict sugar levels are to be maintained for good outcome in stroke patients.
Hypoglycaemia (blood glucose <60 mg/dL) should be treated in patients with acute
ischemic stroke with glucose containing solutions. The goal is to achieve normoglycemia.
Evidence indicates that persistent in-hospital hyperglycaemia has worst outcomes in the
first 24 hours of the stroke episode treatment should be targeted to achieve blood glucose
levels in a range of 140 to 180 mg/dL and to closely monitor to prevent hypoglycaemia in
patients with acute ischemic stroke.
THROMBOLYSIS
The use of thrombolytic agents in acute cerebral infarction has been studied
extensively. Three early intravenous streptokinase trials were stopped because of higher
death rate mainly due to intracerebral bleedings.
The European Co-operative Acute Stroke Study (ECASS) tested recombinant
tissue plasminogen activator (rtPA - 1 mg/kg to 100mg max, 10% as a bolus, then
remainder over 60 min. IV) versus placebo in patients with ischaemic stroke within 6
hours of onset of symptoms. Overall thrombolysis was not beneficial because of excess of
cerebral haemorrhage. However, in those patients who had no signs of major infarction on
initial CT scan, the functional outcome was improved.
The National Institute of Neurological Disorder and Stroke (NINDS) rtPA stroke
study showed a clear benefit for rtPA in selected patients with acute stroke. The NlNDS
study used rtPA versus placebo in patients with acute ischaemic stroke within 3 hours of
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onset. Symptomatic intracerebral haemorrhage occurred in 6.4% patients on rtPA and
0.6% on placebo. There was a nonsignificant reduction in mortality and a significant
absolute increase in number of patients with only minimal disability (32% placebo vs.
44% on rtPA). Thus despite increase in rate of ICH, treatment with IV rtPA within 3 hours
of onset of ischaemic stroke improved clinical outcome.
Finally, ECASS II tested the NINDS dose of rtPA (0.9 mg/kg, max dose of 90 m)
but allowed patients to receive drug up to 6th hour as in ECASS I. No significant benefit
was found.
Many hospitals have developed expert stroke teams to facilitate this treatment. The
drug is now approved in the USA and Canada for acute stroke within 3 hours of onset of
symptoms. Two recent trials (PROACT and PROACT II) using intra-arterial thrombolysis
for acute MCA infarct showed benefit.
ENDOVASCULAR INTERVENTIONS
The number of options for endovascular treatment of ischemic stroke has increased
substantially over the past decade to include intra-arterial fibrinolysis, mechanical clot
retrieval with the Mechanical Embolus Removal in Cerebral Ischemia (Merci) Retrieval
System (Concentric Medical)Inc., Mountain View, CA), mechanical clot aspiration with
the Penumbra System (Penumbra, Inc. Alameda, CA), and acute angioplasty and stenting.
ANTITHROMBOTIC AND ANTIPLATELET DRUGS
HEPARIN: Both unfractionated heparin and low molecular weight heparin has
not shown any benefit in the outcome and neurological worsening of acute ischemic stroke
.It was further associated with increased risk of bleeding complications with early
administration of UFH and LMWH.
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ASPIRIN: Aspirin acts by irreversible inhibition of platelet function by
inactivation of cyclooxygenase. Oral administration of aspirin (initial dose is 325 mg)
within 24 to 48 hours after stroke onset is recommended for treatment of most patients.
OTHER ANTIPLATELET AGENCES:
The role of use of Clopidogrel, intravenous tirofiban and eptifibatide, inhibitors of
glycoprotein IIb/IIIa receptor are not recommended in the use of acute ischemic stroke.
NEUROPROTECTIVE AGENTS:
Neuroprotection refers interventional therapy that is directed to delay the infarction
or salvage the brain tissue of the still viable ischemic penumbra of the ischemic zone.
SEVERAL GROUP OF DRUGS TRIED ARE:
a.) Calcium channel blockers (nicardipine, nimodipine)
b.) NMDA receptor antagonists (Selfotel, Eliprodil),
c.) ICAM 1 antibodies (Enlimonab),
d.) Glutamate antagonist (Lebeluzole),
e.) GABAergic antagonist (Diazepam, Clomethiozole),
f.) Free radical scavengers (Tirilazed, dihydrolipoate),
g.) Inhibitors of lipid peroxidation (Ebselen).
h.) Citicoline, intermediary in the biosynthesis of phosphatidyl choline.
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SURGICAL THERAPY:
Carotid Endarterectomy:
Symptomatic carotid artery stenosis with intraluminal mobile or sessile thrombus
associated with an atherosclerotic plaque at the carotid bifurcation. The indication for this
is controversial. The morbidity associated with surgery appears to be high among patients
who already have intraluminal thrombus demonstrated by cerebral angiography.
SUPPORTIVE CARE:
a.) Nutrition and hydration
b.) Infections
c.) DVT and PE prevention.
d.) Physiotherapy
35
MATERIALS AND METHODS
STUDY DESIGN:
Cross sectional study.
SETTING:
The study on “A Study Of serum uric acid levels in setting of acute ischemic stroke
in GVMCH” was carried out in the Department of Medicine, Government Vellore medical
college and hospital, Vellore.
COLLABORATIVE DEPARTMENTS:
Department of Biochemistry, Neurology, Radiology, Government Vellore Medical
College and Hospital, Vellore.
STUDY DESIGN:
The study will be done in acute ischemic stroke patients admitted as In-patient in
department of General medicine of Government Vellore Medical College and Hospital.
Necessary ethical clearance was obtained from ethical committee, Government Vellore
medical college and hospital, Vellore.
PERIOD OF STUDY: 12 months (01-September- 2016 to 31-August- 2017).
SAMPLE SIZE:
A total sample of 100 patients will be studied using carefully prepared proforma.
Information will be collected through a preformed and pre-tested proforma from each
patient. Fasting blood samples were drawn within 24h of admission, and examined for uric
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acid and a standard battery of biochemical and haematological tests. Qualifying patients
will be undergoing detailed history, clinical, biochemical and radiological examination.
CT/MRI scan of brain was required for the diagnosis of ischemic stroke. Patients without
neuroimaging were classified as having as uncertain stroke type were excluded in
statistical analysis.
INCLUSION CRITERIA:
1.All acute ischemic stroke patients presenting within 24 hours of onset and acute
ischemic stroke confirmed by CT/MRI scan.
EXCLUSION CRITERIA
1. Haemorrhagic stroke 
2. Ischaemic stroke >24 hours from onset
3. CNS tumours 
4. Vasculitic stroke
5. CNS infections 
6. Patients who did not do CT/MRI SCAN
7. Subdural hematoma
8. Past history of PVD
9. Drugs causing hyperuricemia
10. Elevated RFT OR LFT
11. Thyroid disorder
12. COPD (Chronic obstructive pulmonary disease)
13. Chronic inflammatory bowel disease;
14. Excessive alcohol consumption
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ETHICAL CLEARANCE:
This study was approved by the ethical committee of Govt. Vellore Medical
College and Hospital, Vellore-11.
METHODS
After obtaining the verbal consent either from the patient or the relatives, all
patients were evaluated by complete medical history, full neurological examination,
standardized blood tests imaging studies and data was recorded in a standardized sheet
Clinical history was obtained from the patient, his/her relatives or past records.
History regarding diabetic status, hypertension, TIA, smoking, alcoholism, chronic kidney
diseases, COPD, Thyroid disorder was obtained Clinical examination was done to assess
the side of the stroke, Glasgow coma scale on admission, presence of gaze palsy, papillary
abnormality, plantar reflex facial palsy, speech difficulty, admission blood pressure.
Electrocardiography, blood sugar, urea, creatinine, lipid profile, serum uric acid
and CT/MRI-brain were done after admission.
All relevant data were fed into a computer and results were calculated.
DEFINITIONS:
HYPERTENSION :
Hypertension was diagnosed as present if the patients exhibited a systolic blood
pressure 140 mm Hg or a diastolic blood pressure 90 mm Hg, or had a history of diagnosis
of hypertension and anti-hypertensive medications.
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DIABETES:
Diabetes was defined if patients exhibited a fasting glucose level 7.0 mmol/L (126
mg/dL) or had a history of diabetes diagnosis and anti-diabetic medications.
DYSLIPIDEMIA :
A diagnosis of hypercholesterolemia was made for patients with a history of using
cholesterol-lowering agents or who had a cut off of fasting serum total cholesterol level
(200 mg/dL) on admission and LDL cholesterol >130 mg/dl. Hypertriglyceridemia when
the level of Triglycerides ≥ 150 mg/dl, Low HDL cholesterol: <40 mg/dl.
URIC ACID ESTIMATION:
Uric acid level was measured by uric acid oxidase reagent on a Dax analyser
(Bayer-Technicon). The definition of high uric acid level was when patients had more than
7 mg/dl in both men and women.
SMOKING:
A patient was labelled smoker when he had smoked atleast 10 cigarettes per day
for more six month / more or if he had smoked daily for more than a year regardless of the
number [5].
OBESITY:
A patient was defined as obese when his or her BMI was more than or equal to 24.9
kg/m2.
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STATISTICAL ANALYSIS:
The information collected regarding all the selected cases were recorded in a
Master Chart. Data analysis was done with the help of computer using SPSS v16 software.
Using this software range, frequencies, percentages, means, standard deviations, chi
square and 'p' values were calculated. PEARSON chi- square test was used to test the
significance of difference between quantitative variables. A 'p' value less than 0.05 is
taken to denote significant relationship.
40
DEMOGRAPHIC DETAILS OF THE STUDY POPULATION:
TABLE 1: Baseline Characteristics Of Cases.
BASELINE PARAMETERS MEAN± SD
AGE(YEARS) 61.14±12.67
BMI 23.19±3.01
FASTING BLOOD SUGAR (mg/dl) 174.46±74.59
TOTAL CHOLESTROL(mg/dl) 222.13±54.96
TRIGLYCERIDES (mg/dl) 172.85±38.83
LDL (mg/dl) 149.60±42.44
HDL(mg/dl) 43.62±5.70
SYTOLIC BP (mm hg) 165.84±25.09
DIASTOLIC BP (mm hg) 92.11±12.50
URIC ACID(mg/dl) 6.97±1.26
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DEMOGRAPHIC DETAILS OF THE STUDY POPULATION:
AGE AND SEX:
Table 2: Frequency distribution of age of the study population
Age group Frequency (n=100) Percentage %
≤ 40 years 9 9
41-50 years 40 40
51 – 60 years 30 30
> 60 years 21 21
Graph 1: Frequency Distribution Of Age Of The Study Population
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The present study included 100 patients with acute stroke with age ranging
from 29 to 95 years. The mean age of the study group was 61.1± 12.6 years. The
age was stratified and their frequency distribution was shown in table 1. The
majority of the patients are within the age group of50 -70 years (40%). The Mean
age of males in the study is 64.69±12.89 years and that of females is 63.68±11.23
yrs.
Table 3: Frequency distribution of sex of the study population
Sex Frequency (n = 100) Percentage (%)
Male 65 65
Female 35 35
Total 100 100
Graph 2: Frequency distribution of sex of the study population
Of the 100 patients studied, 65 are males and 35 are females (Table 2)
65%
35%
MALE FEMALE
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RISK FACTORS:
AGE WITH BMI:
The BMI was found to be inversely correlated with age by Pearson’s
correlation analysis. On regression analysis, for every one year increase in age,
BMI decreases by a factor of 0.44.
Graph 3: Distribution of age (years) with BMI (BODY MASS INDEX) kg/m2
in study population:
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BMI AND FASTING BLOOD GLUCOSE:
Table 4: Descriptive statistics of elevated BMI and fasting blood sugar in the
study population
Graph 3: Distribution of elevated BMI and fasting blood sugar in the study
population
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Fasting Blood
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Graph 4:  Pearson correlation between BMI and Fasting blood sugar in
patients with acute ischaemic stroke.
In our study majority 2/3 rd (n=66) of the patients had normal BMI and
1/3rd (n=34) of patients are obese, as their BMI was more than or equal to 24.9.
Most of the patients fell into normal BMI. BMI of the study population ranges from
18 to 13.4 with a mean of 23.1 ± 3.01. The fasting blood sugar was elevated in 50
patients and rest of the 50 had normal fasting sugar values. Fasting sugar value
ranges from 88 to 360 mg/dl with a mean of 174 ± 74.5 mg/dl. Pearson correlation
showed that fasting blood sugar increased with increase in BMI (p<0.01). On doing
simple linear regression analysis, For every single unit rise in BMI the fasting
blood sugar will increase by a factor of 6.09. For every one unit rise in cholesterol
levels, FBS rises by a factor 0.25.
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HYPERTENSION, DIABETES MELLITUS AND SMOKING:
Table 5 : Distribution of hypertension, diabetes mellitus and smoking in the
study population
Parameters Yes No
Smoking
(n=100)
26 74
Diabetes mellitus
(n=100)
46 54
Hypertension
(n=100)
68 32
Graph 5: Distribution of hypertension, diabetes mellitus and smoking in the
study population
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Of the risk factors focussed in the study population of acute ischemic stroke
patients namely hypertension, smoking and diabetes mellitus, Hypertension was the
most commonly found to be associated with acute stoke with 68 % (n=68),
followed by diabetes mellitus in 46% (n=46) of patients. Smoking was associated
with 26% (n=26) of which, all of them were males.
DYSLIPIDEMIA:
Table 6: Distribution of dyslipidaemias in the study population with their
descriptive statistics
Dyslipidemias YES NO Mean ± SD (mg/dl)
Hypercholesterolemia 54 46 222.1 ±55.0
Elevated LDL Cholesterol 60 40 149.6 ±42.4
Hypertriglyceridemia 69 31 172.8 ±38.8
Lowered HDL Cholesterol 30 70 43.6±5.7
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Graph 6: Distribution of dyslipidaemias in the study population
Most of the patients with acute stroke were found to have dyslipidemia in
one or the other form of abnormal lipid profile. Hypercholesterolemia (total
cholesterol >200 mg /dl) was found in 54% of patients (n=54).Patients with
hypertriglyceridemia (triglycerides >150 mg/dl)was found to be69% (n=69). HDL
cholesterol which was considered to be beneficial was low (<40 mg/dl) in 30% of
cases (n = 30).
The data on subjecting to Pearson correlation it was found that, As age
increase, total cholesterol and triglycerides levels decreases. Regression analysis
showed that for every unit rise in age the total cholesterol and TGL decreased by a
factor of 0.30 (p< 0.05) and 0.39 (p<0.05) respectively.
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Graph 7: Distribution of triglycerides  in the study population with  their age :
Graph 8 : Distribution of total cholesterol to their ages in study patients:
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BLOOD PRESSURE:
Table 7: Distribution of Blood Pressure in the study population with their
discriptive statistics
Graph 9: Distribution of Blood Pressure in the study population
In our study, as already learnt from the history most of the patients had
elevated blood pressure on measuring the blood pressure it was found that most of
patients had elevated Systolic blood pressure (>140 mm of Hg) in 91% (n=91).
Diastolic blood pressure was elevated (>90 mmhg) in 43% of patients.
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Blood pressure Normotensive Hypertensive Mean ± SD
Systolic BP
(mm of Hg) 19 81 165.84±25.09
Diastolic BP
(mm of Hg) 43 57 92.11±12.50
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URIC ACID LEVELS
Table 8: Distribution of serum uric acid levels in the patients with acute
ischemic stroke.
Graph 10 : Distribution of serum uric acid levels in the patients with acute
ischemic stroke.
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In the present study, the mean serum uric acid level was 7 mg/dl with a
standard deviation of 1.2 mg/dl. The minimum value noted was 4.5 mg/dl and the
maximum serum uric acid levels was 10.1 mg/dl. Hyperuricemia (elevated serum
uric acid levels> 7mg/dl ) was noted in 46% of cases (n=46) and the other 54 % had
uric acid levels below 7 mg/dl of which 6% (n=6)had uric acid levels below 5mg/dl
and 48% (n=48) had serum uric acid levels within 5 to 7 mg/dl.
RELATIONSHIP BETWEEN URIC ACID AND OTHER PARAMETERS:
 AGE AND URIC ACID:
Table 9: Distribution of age with serum uric acid levels in study population:
Age Group
Serum Uric Acid Levels
Total
Normal Hyperuricemic
Upto 40 years 2 7 9
41 to 50 years 19 21 40
51 to 60 years 18 12 30
>60 years 15 06 21
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Table 10: Stratified age group in the study patients with uric acid levels:
p value was significant in Pearson chi square test(p <0.05)
Graph 11: Distribution of serum uric acid with different age groups:
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In present study correlation between age and serum uric acid was done using
bivariate analysis which showed no correlation between the various age group and
serum uric acid levels in acute ischemic stroke. But interestingly when another
bivariate analysis was done with stratifying the patients into two group, first group
as age less than 60years(n=49) and other second group with age more than 60 years
of age(n=51),a statistically ignificant correlation (p value <0.05) between the age
group and SUA was found.
TABLE 11 : SEX AND URIC ACID LEVELS
In current study, no significant correlation between the sex (gender) distribution
and SUA in patients with ischemic stroke was found.
SEX
SERUM URIC ACID LEVELS
NORMAL HYPERURICEMIC TOTAL
MALE 35 30 65
FEMALE 19 16 35
100
55
 BODY MASS INDEX AND URIC ACID:
TABLE 12: BMI AND URIC ACID LEVELS
BMI
Uric acid
TOTALNORMAL HYPER
UPTO 24.9 44 22 66
>25 10 24 34
100
p value was significant in Pearson chi square test(p <0.01)
Graph 12: Distribution of serum uric acid with BMI of the study population:
44
10
22 24
0
5
10
15
20
25
30
35
40
45
50
upto 24.9 >24.9
normal sua hyperuricemia
56
In our study, we have (n=34) thirty-four patients with BMI in the range of
obesity, other 66 patients had BMI within normal range. Using bivariate analysis,
with Pearson chi square test in the present study we found a statistically significant
correlation between BMI and serum uric acid(p<0.01). On simple linear regression
analysis, for every one unit rise in serum uric acid, BMI(body mass index)
increases by a factor of 1.3.
 Graph 13: Distribution of serum uric acid with BMI in study population;
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 DIABETES MELLITUS AND URIC ACID:
TABLE13:Distribution of diabetes mellitus and SUA levels in our study:
SERUM URIC ACID LEVELS
NORMAL HYPERURICEMIC TOTAL
DIABETES 21 25 46
NON-DIABETIC 33 21 54
Graph 14: Distribution of serum uric acid levels with FBS Fasting blood
glucose levels in our study population:
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In our current study, there was a statistically significant positive correlation
between fasting blood sugar and serum uric acid level (p <0.05). On simple linear
regression analysis, For every single unit rise in BMI there was an increase in
fasting blood glucose by factor of 6.09. For every one unit rise in serum uric acid,
FBS increases by a factor of 19.67.
LIPID PROFILE AND URIC ACIDTABLE
Table 14: Distribution of Total Cholesterol and uric acid.
p value was significant in Pearson chi square test (p <0.01)
A statistically significant correlation was foundusing bivariate analysis using
Pearson chi square test(p value <0.01) between hypercholesterolemia (n=54)
patients with elevated serum uric acid with acute ischemic stroke. on simple linear
regression analysis, for every one unit rise in serum uric acid T. Cholesterol
increases by a factor of 21.21.
NORMAL HYPERURICEMIA TOTAL
NORMAL 34 12 46
HYPERCHOLESTROLEMIA 20 34 54
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Graph 15: Distribution of Total Cholesterol and uric acid in our patients:
Table 15: Distribution of TGL with  serum uric acid in our study population:
p value was significant in Pearson chi square test (p <0.01)
In our current study around sixty nine patients (n=69) had
hypertriglyceridemia and a statistically significant correlation was found in
between patients with hypertriglyceridemia and elevated SUA using bivariate
analysis and  pearson chi square  test with a p value(p value <0.01). on simple
linear regression analysis, for every one unit rise in serum uric acid TGL increases
by a factor of 15.1
NORMAL HYPERURICEMIA TOTAL
NORMAL 22 09 31
HYPER TGL 32 37 69
60
Graph 16: Distribution of TGL with   serum uric acid in our study population:
Table 16: Distribution of LDL Cholesterol and uric acid in our study
population
p value was significant in Pearson chi square test (p <0.01)
NORMAL HYPERURICEMIA TOTAL
NORMAL 29 11 40
HYPERCHOLESTROLEMIA 25 35 60
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In the present study, a statistically significant correlation was found using
bivariate analysis using Pearson chi square with p value significant (pvalue<0.01)
between patients with elevated LDL cholesterol (n=60) and serum uric acid in
stroke patients.on simple linear regression analysis, for every one unit rise in serum
uric acid LDL increases by a factor of 15.38
Graph 17:Distribution of LDL Cholesterol  and uric acid in our study
population
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Table17: Distribution of HDLCholesterol and uric acid in our study
population:
p value is statistically significant with (p value <0.05)
In our present study, significant positive correlation was found between
HDL cholesterol and serum uric acid levels (p<0.05). on simple linear regression
analysis, for every one unit rise in serum uric acid HDL increases by a factor of
1.03.
Graph 18 :: Distribution of HDL Cholesterol and uric acid in our study
population
NORMAL HYPERURICEMIA TOTAL
NORMAL 20 10 30
HYPERCHOLESTROLEMIA 34 36 70
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BLOOD PRESSURE AND URIC ACID LEVELS:
SYSTOLIC BP WITH SERUM URIC ACID :
Table 18: Distribution of serum uric acid with systolic bp in our study
population:
p value was significant in Pearson chi square test (p <0.01)
Graph 19: Distribution of serum uric acid with systolic bp in our study
population:
SYSTOLIC BP NORMAL HYPERURICEMIA TOTAL
NORMAL 14 5 19
SYSTOLIC
HYPERTENSION
40 41 81
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In the present study a statistically significant correlation was found between
SUA and Systolic BP, using bivariate analysis using pearson chi square with p
value significant (pvalue<0.01).on simple linear regression analysis, for every one
unit rise in serum uric acid Sys. BP increases by a factor of 9.7
DIASTOLIC BP WITH SERUM URC ACID :
Table19 : Distribution of serum uric acid with Diastolic BP in our study
population:
p value was significant in Pearson chi square test (p <0.01)
In our current study, we found there was significant correlation between
hypertension and elevated serum uric acid levels using Pearson chi square test with
p value(p=<0.01). Interestingly our study showed a significant correlation between
diastolic more than systolic blood pressure with elevated serum uric acid as an
important risk factor for the development of acute ischemic stroke.
On simple linear regression analysis, for every one unit rise in serum uric
acid Diastolic. BP increased by a factor of 3.8.
NORMAL HYPERURICEMIA TOTAL
NORMAL 30 13 43
DIASTOLIC BP 24 33 57
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Graph 20 : Distribution of serum uric acid with Diastolic BP in our study
population:
TABLE 20 : Distribution of Smokers and uric acid levels in acute ischemic
stroke patients:
HISTORY
SMOKING NORMAL HYPERURICEMIA TOTAL
YES 12 14 26
NO 42 32 74
In our study, no statistical significance was found in patients with history of
smoking and elevated serum uric acid in acute ischemic stroke patients.
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MULTIPLE LOGISTIC REGRESSION:
In our study Multiple, logistic regression analysis was done between
multiple parameters that were significant in bivariate analysis like BMI (Body mass
index), Blood pressure (systolic and diastolic blood pressure), Total cholesterol,
Triglycerides. Of those BMI (body mass index), Diastolic blood pressure, Total
cholesterol were the ones that was statistically significant (p value< 0.05). whereas
systolic blood pressure, triglycerides, and LDL cholesterol that was significant in
bivariate analysis was not statistically significant.
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DISCUSSION
100 cases of acute ischemic stroke within 24 hours of onset were admitted in
the department of General Medicine, Government Vellore Medical College and
hospital during the period of October 2016 to May 2017.
Among total number stroke patients 100 patients who underwent CT/MRI
scan, and diagnosed to have acute ischemic stroke only then they were included in
the statistical analysis.
AGE DISTRIBUTION:
Age is a non-modifiable risk factor which has a significant correlation
between with increased incidence of stroke. Copenhagen stroke study(17) by
Nakayama et al. suggest stroke is a disease of elderly and age plays a major role in
the prognosis and recovery of the patients.
Our study correlates well with the  finding of Kuzuya et al. that as age
increases there is an significant increase in SUA which independent of other
factors, which further increases the risk of stroke(31). Our study also has shown a
similar result ,As age increased ( > 60 years of age) there was as  statistically
significant increase in SUA in our acute ischemic stroke patients.
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SEX DISTRIBUTION:
In Journal of American heart association, Zhong et al. published that  there
was no significant sex difference was found with hyperuricemia in males and
females but a significant relation with modest increase in the risk of stroke was
associated with both male and female with elevated serum uric acid(32),In our
study also there was no significant correlation between sex difference and serum
uric acid.
RISK FACTORS IN STROKE: 
HYPERTENSION:
In the present study, 68 percentage of cases were hypertensives.
Hypertension is an important risk factor for stroke(33).There are number of novel
studies that show significant correlation between hypertension and
hyperuricemia(34)(35) . Hyperuricemia is an independent predictor of hypertension
and is present in 25% of patients with new-onset primary hypertension who were
not treated previously(36). This hyperuricemia in hypertensives can be explained
due to reduced renal perfusion which stimulates urate reabsorption due to decrease
in renal blood flow(37)Experimentally-induced hyperuricemia also increased the
blood pressure in rats by a renal mechanism linked to inhibition of nitric oxide
(NO), activation of the renin–angiotensin system, and development of renal
arteriosclerosis(38).
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Once renal arteriosclerosis develops, the kidney plays a major role in the
maintenance of hyper- tension(39)Prolonged elevated serum uric acid  in rats also
caused progressive kidney injury via a crystalline-independent mechanism(38)and
accelerated established renal disease(40). Finally, UA stimulated synthesis of
monocyte chemoattractant protein-1 by the rat vascular smooth muscle cells(41)and
this is known to stimulate macrophage infiltration of atherosclerotic vessels (42)
Thus, we know atherosclerotic vessels is an important source of thrombus
increasing the risk of stroke(43).Thereby suggesting that elevated SUA in
hypertensives is an important atherogenic risk factor that increases the occurrence
of acute ischemic stroke(44).
As various studies suggest, In our study there was very high statitcallly
significant correlation (pvalue<0.01) between both systolic blood pressure(mean
165.84±25.09 mmhg) as well as diastolic blood pressure (mean 92.11±12.50mmhg)
andelevated serum uric acid levels in acute ischemic stroke patients. Thus,helping
us suggest that hypertensive patients with elevated serum uric acid are at risk for
acute ischemic stroke.
4.DIABETES:
In our study 50 % of patients were diabetics. Diabetes is an important cause
of cardiovascular risk factors like stroke and myocardial infarction. Dehgan et al.
found that hyperuricemia is a strong and  independent risk factor for diabetes(45).
Hyperuricemia is an important risk factor and strong predictor of stroke due to
diabetes independently of other risk factors (46).Hyperuricemia is an important risk
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factor for the development of diabetes and diabetic nephropathy(47).Emerging
studies are also suggestive that hyperuricemia as an important risk factor for insulin
resistance(48). In turn insulin resistance has shown to increases purine biosynthesis
and turnover, with its attendant increase in SUA levels. In contrast to the popular
belief our study showed that there was no significance between diabetes and serum
uric acid levels this result could be due to small sample size.
BMI :
Body mass index has a significant correlation with hyperuricemia and risk of
stroke. Bonoro et al. data states that elevated uric acid is associated with multiple
components of metabolic /insulin resistance syndrome In addition, these data
suggest that obesity and central body fat distribution, and not hyperinsulinemia &
insulin resistance, that plays a major role in linking hyperuricemia with CVD risk
factors. Dyslipidaemia is related to hyperuricemia independently of obesity and
central body fat distribution.(49) Oyama et al  shows clearly that serum uric acid
levels are significantly increased with increased BMI and could be used as one of
indicators for risk factors stratification  even in early adolescence.(50)
DYSLIPIDEMIA:
In a large  meta-analysis of 90,000 patients showed that administration of
statins reduces the risk of stroke among patients with coronary heart disease and
those at increased risk for cerebrovascular disease and that this risk reduction is
primarily related to the extent to which LDL-C levels are lowered. (51)
Dyslipidaemia is a risk factor for cerebrovascular accident ,its relation with serum
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uric acid is as SUA concentration is positively correlated with Triglycerides, Total
Cholesterol, LDL-Cholesterol, and negatively correlated with HDL-C.
However, in the acute stroke setting, several studies have shown the
opposite; that is, low cholesterol levels are associated with short-term mortality or
worse functional outcome in patients with ischemic stroke, particularly in those
who are older(52).On the contrary, in patients with prior cerebrovascular disease,
high levels of total cholesterol increase the risk of myocardial infarction , whereas
treatment with a statin reduces the incidence of major cardiovascular events in this
population.(53)(54) . Studies also suggest that administration of statins reduces the
serum uric acid levels and also improve renal functions thus thereby reducing the
additional risk of hyperuricemia for cerebrovascular stroke.(55)(56)
In our study, we also observed that SUA levels were associated with TG and
non-HDL-C(51) that suggesting that serum uric acid as an additional risk factor for
the incidence of acute stroke in already high risk patients.
SMOKING:
Currently there are no study relating uric acid with smoking in stroke patients.
In our study also there was no statistically significant correlation between smoking
and uric acid in acute ischemic stroke patients.
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URIC ACID :
Free radical activity is characteristically increased in patients with any one
of several major cardiovascular risk factors, and is thought to play a key role in the
early development of atherosclerosis. As an antioxidant, Uric acid could be
expected to confer protection against free radicals. There are accumulating
evidences suggesting that uric acid as a causal factor for number of cardiovascular
complications. Thus abnormally high level of serum uric acid in blood suggest that
there is increased oxidative stress which induces endothelial dysfunction thereby
cerebrovascular slow blood flow(57).
There are different mechanism in which UA may directly affect
atherogenesis or the clinical course of cerebrovascular disease. Cerebral ischemia is
a result of free radical mediated oxidative damage and complex cascade of
metabolic events. powerful oxidative radicals that are generated during the process
causes lipid peroxidation that irreversibly damages plasma and mitochondrial
membranes (58).thus the importance of local antioxidants is clearly understood
from the above explanations. Stroke is associated with rapid reduction in serum
antioxidants(59).Uric acid is the most abundant aqueous antioxidant in humans and
contributes to the major junk of the antioxidant capacity of plasma. It is particularly
effective in quenching superoxide radicals and peroxynitrite radical and may
protect the  neuronal cells from lipid peroxidative damage.(60) It might therefore
be expected that having an elevated SUA level during an acute stroke would be
beneficial.
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But contrary to the traditional belief of anti-oxidant properties of uric acid
large series of study has shown the opposite that uric acid acts as pro oxidant and
accentuates the inflammatory cascade and therefore causing damage and poor
outcome (61)
One hypothesis  would be that UA can become a pro-oxidant under certain
circumstances, particularly if other antioxidants such as ascorbate are lowThus, in
patients with acute stroke the fall in ascorbate levels could predispose the SUA to
take on pro-oxidant properties.(62) Consistent with this hypothesis is the
observation that in acute stroke, those with high SUA and low ascorbate levels have
the worst outcome.(63)
Other hypothesis, uric acid causes vascular disease by causing vascular
endothelial dysfunction. Uric acid stimulates LDL cholesterol oxidation and
granulocyte adherence to the endothelium thus favouring endothelial
injury(64).uric acid also has the tendency to form crystals in atherosclerotic
plaque.(65)
Uric acid also increases its cerebrovascular risk with its association with
metabolic syndrome through its relation with insulin resistance(66) .as insulin
resistance is directly related to the level of serum uric acid .serum uric acid induces
insulin resistance by its ability to induce endothelial dysfunction through nitric
oxide bioavailability inhibition (67), Because insulin requires NO to stimulate
glucose uptake, it has been hypothesized that hyperuricemia may have a key role in
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the pathogenesis of IR(68).In our study, we found that hyperuricemia independent
of the other risk factors of metabolic syndrome like blood pressure, cholesterol,
triglyceride levels hasbeen an important accentuating factor to other risk factor of
acute ischemic stroke.
In our study, also we have found a negative correlation with age and body
mass index along with low cholesterol associated with elderly population.
Hypercholesterolemia and triglyceridemia are an important risk factor of ischemic
stroke as shown by numbers of studies on its risk and administration of statins and
fenofibrate has reduced the risk of acute stroke in patients with CAD and increased
risk of cardiovascular diseases(69). But several studies have shown that low
cholesterol levels are associated which poor prognosis in an setting of acute
ischemic stroke particularly elderly people(70)(71). This paradox might be
explained by the fact that these patients might had poor nutritional status or severe
disease (71).
Thus more importantly this finding should not be misinterpreted as elevated
cholesterol levels might be considered as a good prognostic factor in acute
ischemic stroke as we have a number of study suggestive that elevated cholesterol
levels are risk factor for acute ischemic stroke which doesn’t confer protection to
these study population against stroke.
Thus, we had concluded in our study that SUA (serum uric acid) is an
important risk factor for the development of acute ischemic stroke. Eventhough the
traditional risk factors of stroke like hypertension, diabetes mellitus, dyslipidaemia
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is being treated aggressively for reducing the incidence of stroke there is a need for
identifying other modifiable risk factors for the associated with mortality and
morbidity of stroke.
Therefore, it would be prudent for us to use allopurinol and other uricosuric
drug other drug like losartan and fenofibrate (72).Statins also has shown to reduce
SUA(73) and preserve renal function (74)which can help prevents vascular
catastrophe in  people with high risk factors(75).Thus, these treatment with drugs
lowering serum uric acid might be helpful in reducing the risk of acute ischemic
stroke. However, further prospective studies are needed to assess the precise role of
elevated serum uric acid in these high-risk patients and the use of drugs to treat
them before the onset of acute ischemic stroke has to be studied to be
recommended for routine use in detail.
LIMITATIONS OF THE STUDY:
1. The number of patients evaluated had been small and this could have
influenced the results of the study.
2. Large samples could not be entered into the study because most of the
patients admitted after 24 hours of onset of stroke.
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CONCLUSION
The following conclusions were derived from the study.
1. The serum Uric acid is an important risk factor for the onset of acute ischemic
stroke of independent of age, BMI, hypertension, diabetes, dyslipidaemia.
2. For every one unit rise in serum uric acid, we found a significant rise of risk factors
i.e. BMI rise by factor of 1.3, fasting blood sugar rise by factor of 19.67.
3. For every one unit rise in serum uric acid, total cholesterol rises by 21.21,
triglycerides by 15.1, LDL cholesterol by 5.28.
4. For every one unit rise in serum uric acid, systolic blood pressure rises by factor of
9.7, diastolic blood pressure rises by factor of 3.8.
5. Our study showed a significant association between serum uric acid and acute
ischemic stroke. This brings new insight into uric acid being used in day to day
practice and a trigger for physician to screen patients with risk factors and
hyperuricemia for acute ischemic stroke.
6. Eventhough traditional risk factors of stroke like hypertension, diabetes,
hyperlipidaemia is treated aggressively, our study opens up the possible suggestion
of additional therapeutic administration of drugs that reduce serum uric acid to
patients with high risk factors associated with hyperuricemia to decline the
incidence of acute ischemic stroke.
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PROFORMA
NAME :
AGE/SEX :
IP NO :
OCCUPATION :
ADDRESS :
FAMILY INCOME :
PRESENTING COMPLAINTS : YES NO
 WEAKNESS
 HEADACHE
 VOMITING
 LOSS OF CONSCIOUS
 SEIZURES
 UNSTEADY GAIT
 SPEECH DISTURBANCES
ONSET OF SYMPTOMS : SUDDEN GRADUAL
PAST HISTORY: YES                       NO
1. SYSTEMIC HYPERTENSION
2. DIABETES MELLITUS
3. PREVIOUS HISTORY OF STROKE OR TIA
4. RHEUMATIC HEART DISEASE
5. CORONARY ARTERY DISEASE
6. ATRIAL FIBRILLATION
7. SMOKING
8. ALCOHOLISM
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FAMILY HISTORY:
CLINICAL EXAMINATION:
 HEIGHT
 WEIGHT
 BMI
 BP
 TEMPERATURE
 CARDIOVASCULAR SYSTEM
 RESPIRATORY SYSTEM
 ABDOMEN
 CNS
LAB INVESTIGATIONS
CBC
RFT
FBS / PPBS (IF NEEDED)
URINE SUGAR
LIPID PROFILE
ECG
ECHOCARDIOGRAM
(CT / MRI BRAIN) INFRACTION VESSEL INVOLVEMENT
MCA
ACA
PCA
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PATIENT CONSENT FORM
STUDY DETAIL :
STUDY CENTRE :
PATIENT’S NAME :
PATIENT’S AGE :
IDENTIFICATION NUMBER:
I confirm that I have understood the purpose and procedure of the above
study. I have the opportunity to ask questions and all my questions and doubts have
been answered to my complete satisfaction.
I understand that my participation in the study is voluntary and that I am free
to withdraw at any time without giving reason, without my legal rights being
affected.
I understand that the sponsor of the clinical study, others working on the
sponsor’s behalf, the ethical committee and the regulatory authorities will not need
my permission to look at my health records, both in respect of the current study and
any further research that may be conducted in relation to it, even if I withdraw from
the study I agree to this access. However, I understand that my identity would not
be revealed in any information released to third parties or published, unless as
required under the law. I agree not to restrict the use of any data or results that arise
from this study.
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I hereby consent to participate in this study.
I hereby give permission to undergo complete clinical examination and
diagnostic tests including haematological, biochemical, radiological tests.
Signature/thumb impression:
Patient’s name and address:                                             Place:
Date:
Signature of the investigator:
Name of the investigator:                                                  Place:
Date:
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: A STUDY OF SERUM URIC ACID LEVELS IN A SETTING OF
ACUTE ISCHEMIC STROKE IN GVMCH VELLORE
:
தந்ைத /தாயாரெ்பயர் :
/ :
I. நான் ேமேல உைரயய்
ெகாண்ேடன் ,
.
II. நான் இந்த தன்னிசை்சயாகத் தான்
, நான் , காரணம்
இந்த
, ெசய்வதனால் என் சட்ட
பந்தபட்ட உரிைமகள்
நான் .
III. இந்த அவரக்ள் சார்பாக
, இந்த ,
இதன்சம் பந்தமாக , என்
சம்பந்தப்பட்ட
காண . இந்த
ஆராய் , இந்த
அைடயாளம்
நான் .
IV. இந்த ஆராய்ச்
சார்ந்த
நான்
.
V. நான்இந்த ெபறசம்மதம் .
1) / ரவ்
/
ெபயர் /
2) ,
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KEY TO MASTER CHART :
1. Age in years
2. Sex; 1=male, 2=female
3. Systolic BP in mmhg.
4. Diastolic BP in mmhg
5. Body mass index in kg/m2
6. Fasting blood glucose in mg/dl
7. Serum Urea in mg/dl
8. Serum creatinine in mg/dl
9. Total Cholesterol in mg/dl
10. Triglycerides (TGL) in mg/dl
11. Low density lipoprotein cholesterol in mg/dl
12. High density lipoprotein cholesterol in mg/dl
13. Serum uric acid in mg/dl
14. Smoking; 1= yes , 2 = no
15. Diabetes mellitus; 1= yes, 2= no
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MASTER CHART
S.No. AGE SEX SystolicBP Diastolic BMI
FASTING
GLUCOSE UREA
CREAT
ININE
Total
Cholestrol TGL LDL HDL
URIC
ACID
SMO
KING DM
1 61 1 160 100 28.2 235 35 1.1 196 140 136 46 6.8 2 1
2 63 1 136 88 22.4 187 42 0.8 223 184 128 49 7.5 2 2
3 67 1 200 100 23.5 247 21 0.5 206 172 136 46 8.3 2 1
4 45 2 168 96 18.8 245 32 0.8 156 164 118 42 6.6 2 1
5 59 1 156 108 21.5 244 39 0.9 186 156 124 38 6.8 2 1
6 60 1 196 110 23 142 33 1.3 202 194 118 36 7.6 2 2
7 35 2 220 106 26.4 110 26 0.5 221 165 122 44 9.6 2 2
8 40 1 136 88 21.1 167 19 0.6 220 178 146 42 4.3 1 2
9 55 1 142 90 22.7 213 38 0.9 175 168 120 47 4.8 2 1
10 41 1 172 90 19.2 173 23 0.7 256 183 172 46 5.6 1 2
11 45 1 188 100 28.5 108 28 0.5 202 173 154 52 4.8 1 2
12 50 2 120 82 19.7 289 45 0.7 186 149 118 44 6.2 2 1
13 63 1 146 96 22.1 207 31 0.8 148 128 102 40 6.6 2 1
14 52 1 172 88 27.4 154 22 0.4 240 180 148 38 7 2 2
15 54 1 210 100 28 278 41 0.6 286 193 164 42 9.3 2 1
16 50 1 154 88 25.4 98 39 0.7 204 183 150 46 6.4 1 2
17 75 2 168 90 23.5 165 39 0.9 293 190 158 48 5.4 2 2
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18 66 2 128 98 20.6 116 42 1.4 308 198 168 52 4.6 2 2
19 70 1 200 88 19.6 122 36 0.5 285 178 164 49 7.6 2 2
20 49 1 l 80 20.3 119 46 1.2 214 180 160 40 6.1 1 2
21 50 2 170 96 21.4 188 23 0.6 169 138 126 48 5.8 2 2
22 70 2 186 90 24.3 312 28 0.7 198 140 116 38 6.8 2 1
23 50 1 210 140 27.3 289 33 0.7 227 180 120 49 8..8 2 1
24 75 1 180 106 24.3 178 38 0.8 198 138 128 39 6.4 2 2
25 29 2 176 92 25.8 317 27 0.9 256 173 104 48 7.4 2 1
26 60 1 206 98 27.4 326 18 0.5 278 183 122 46 7.8 2 1
27 55 1 160 80 18.4 103 39 0.6 180 140 103 48 6.3 1 2
28 66 1 156 76 18.7 253 33 0.7 225 164 128 36 5.6 2 2
29 70 2 172 90 25.7 298 26 0.8 274 166 131 46 6.3 2 1
30 60 1 186 92 25.4 276 36 0.9 288 174 127 50 7.4 1 1
31 50 1 122 82 21.4 96 24 0.6 153 120 98 48 4.8 1 2
32 60 2 190 86 24.6 210 35 0.9 228 146 134 47 5.8 2 1
33 60 1 210 98 26.5 90 28 0.7 186 138 118 52 7 2 2
34 57 1 176 88 18.5 184 29 0.7 188 112 144 42 6.1 1 2
35 95 2 148 80 16.8 113 39 0.8 188 146 102 42 5.6 2 2
36 65 1 150 86 18.8 176 25 0.6 226 164 112 48 5.8 2 2
37 60 2 168 78 23.4 276 37 0.8 287 198 184 42 6.2 2 1
38 65 1 136 85 18.7 198 22 0.7 196 136 98 46 4.6 1 2
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39 72 2 198 88 20.4 195 34 1.1 261 164 139 49 7.5 2 2
40 52 1 150 80 20.6 145 18 1.3 192 168 140 39 5.2 2 2
41 85 1 142 70 21.6 256 26 0.7 265 188 169 52 7.6 2 1
42 76 2 150 86 22.8 110 48 0.8 168 126 112 48 6.5 2 2
43 72 1 176 84 23.1 212 25 0.9 204 188 165 44 5.8 2 1
44 60 1 120 84 19.2 162 34 0.8 158 148 132 34 5.2 1 2
45 40 1 192 88 26.2 263 23 1.2 216 189 143 48 8.1 1 1
46 65 1 180 100 19.4 174 28 0.7 158 124 120 42 7.4 2 2
47 66 2 122 80 24.1 210 39 0.6 214 179 163 56 8.1 2 1
48 70 1 164 88 18 112 27 0.6 206 185 114 42 6.7 2 2
49 56 1 132 80 20.6 167 36 0.8 186 163 103 48 4.2 1 2
50 52 2 188 98 26.7 172 35 0.9 178 142 116 48 6.6 2 2
51 55 2 190 90 19.7 110 29 1 198 140 98 50 7.6 2 2
52 67 1 140 90 23.4 135 56 0.9 247 180 143 43 5.8 2 2
53 50 2 170 88 20.5 318 38 0.8 210 168 120 47 9.6 1 1
54 46 1 126 78 24.8 238 46 0.5 242 148 110 52 10.1 1 1
55 75 2 190 110 18.5 107 27 1.2 140 112 89 50 7.6 2 2
56 70 1 132 60 24.5 146 48 0.6 270 198 165 44 5.5 1 2
57 67 1 170 90 21.2 176 38 1 186 140 130 48 6.1 2 2
58 89 2 160 80 19.2 185 28 0.8 176 134 110 40 5.8 2 2
59 70 2 150 70 19.8 115 37 1.1 196 142 142 37 4.7 2 2
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60 76 1 180 88 25.8 198 43 1 290 180 189 38 6.4 2 2
61 52 1 122 78 20.3 186 39 0.9 203 150 122 49 5.4 1 2
62 60 1 198 116 27.9 146 45 0.6 276 181 169 50 7.4 2 2
63 70 2 180 120 19.7 152 29 0.7 180 146 120 46 6.6 2 2
64 52 2 190 98 18.9 106 26 0.5 169 132 110 45 6.4 2 2
65 58 1 160 80 22.4 143 34 0.6 188 178 141 34 6.2 1 2
66 63 1 186 90 23.8 174 33 0.8 200 182 134 40 6.7 2 2
67 40 2 140 80 23.7 185 30 1.3 186 43 120 46 5.1 2 2
68 75 1 180 100 20.1 198 32 1.2 206 157 132 56 6.4 2 2
69 65 2 190 90 23.2 201 45 0.9 190 169 156 48 7.4 2 1
70 55 2 210 110 21.8 107 44 1 210 187 140 41 8.4 2 2
71 65 1 176 92 24 176 31 1.1 180 143 116 48 6 Y 2
72 65 1 180 130 22.2 234 48 0.7 216 186 170 41 7.6 2 1
73 40 2 136 80 21.1 168 34 0.8 180 145 108 44 5.8 2 2
74 75 1 138 80 22.3 157 28 0.8 198 140 116 46 4.7 1 2
75 45 2 160 98 24.4 118 33 1.2 196 136 117 42 5 2 2
76 57 2 190 90 21.4 146 25 1 179 131 120 38 8.4 2 2
77 70 1 130 80 20.4 183 30 1.2 189 132 114 46 4.2 2 2
78 75 1 176 110 19.1 212 36 0.9 189 136 135 47 6.8 2 1
79 73 1 150 80 22 235 45 0.6 203 198 140 42 6.6 2 1
80 49 1 180 102 24.6 360 44 1 184 203 187 48 9.2 1 1
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81 37 1 184 92 25.5 289 40 1 301 198 188 48 6.6 1 1
82 78 1 145 90 21 114 38 0.6 302 131 188 39 6.7 2 2
83 48 2 136 80 22.3 178 27 0.7 174 186 142 40 5.4 2 2
84 75 1 180 92 21.1 97 34 0.8 189 163 98 47 5.9 2 2
85 75 1 190 78 19.4 287 48 0.9 210 176 125 41 7.5 1 1
86 58 2 210 130 24.5 312 46 1.2 362 190 163 45 8.7 2 1
87 70 2 188 98 19.6 88 37 0.7 168 130 99 48 7.9 2 2
88 83 1 140 70 18 116 22 0.6 146 122 188 40 5.7 2 2
89 70 2 160 80 23.3 120 39 0.8 154 124 103 44 6.5 2 2
90 67 2 134 88 24.1 206 36 1 264 268 164 38 6.8 2 1
91 52 1 168 80 24 234 39 1.3 218 175 140 47 7.6 1 1
92 60 1 180 120 27.9 146 45 1 280 194 168 48 8.6 2 2
93 70 2 180 120 19.7 152 29 0.7 180 146 120 46 6.6 2 2
94 52 2 190 86 20.4 106 26 0.5 169 146 110 45 6.4 2 2
95 58 1 160 80 22.4 143 34 0.6 188 150 141 34 7.6 1 2
96 63 1 186 90 23.8 174 33 0.8 200 180 131 40 6.7 2 2
97 40 2 140 80 18.6 185 30 1.3 186 146 120 46 5.1 2 2
98 75 2 180 100 20.1 198 32 1.2 206 157 132 56 6.4 2 2
99 65 2 190 90 23.2 201 45 0.9 190 169 156 48 7.4 2 1
100 55 2 210 110 21.8 107 44 1 210 187 140 41 8.4 2 2
